Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Uralyt-U Combined With Febuxostat in the Treatment of Hyperuricemia With Uric Acid Stones
NCT04352153Unknown
- Sponsor
- Aipeng Medical
- Start
- Apr 2020
- Primary completion
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of potassium sodium hydrogen citrate in hyperuricemia and Uric acid nephrolithiasis (2 arms), sponsored by Aipeng Medical. Primary endpoint: Uric acid stones at 6 months. Status: unknown.
02
Drugs
potassium sodium hydrogen citrate
03
Conditions
hyperuricemiaUric acid nephrolithiasis
Beyond the preview
Go deeper on NCT04352153.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04352153.